COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 195 filers reported holding COHERUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $90,508 | -9.2% | 24,200 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $99,649 | -19.2% | 23,337 | +29.4% | 0.00% | 0.0% |
| Q1 2023 | $123,318 | -11.3% | 18,029 | +2.8% | 0.00% | 0.0% |
| Q4 2022 | $138,956 | -14.2% | 17,545 | +4.2% | 0.00% | -50.0% |
| Q3 2022 | $162,000 | +33.9% | 16,832 | +0.5% | 0.00% | +100.0% |
| Q2 2022 | $121,000 | -43.5% | 16,753 | +0.9% | 0.00% | -50.0% |
| Q1 2022 | $214,000 | -18.6% | 16,605 | +0.8% | 0.00% | 0.0% |
| Q4 2021 | $263,000 | -0.8% | 16,467 | -0.2% | 0.00% | 0.0% |
| Q3 2021 | $265,000 | +21.0% | 16,507 | +4.3% | 0.00% | 0.0% |
| Q2 2021 | $219,000 | -10.6% | 15,830 | -5.7% | 0.00% | 0.0% |
| Q1 2021 | $245,000 | -14.9% | 16,779 | +1.2% | 0.00% | -33.3% |
| Q4 2020 | $288,000 | -8.3% | 16,582 | -3.1% | 0.00% | 0.0% |
| Q3 2020 | $314,000 | +38.9% | 17,118 | +35.2% | 0.00% | 0.0% |
| Q2 2020 | $226,000 | +13.0% | 12,663 | +2.6% | 0.00% | 0.0% |
| Q1 2020 | $200,000 | – | 12,348 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |